Lenalidomide for Follicular Lymphoma User Reviews
Brand names: Revlimid
See also:
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Gazyva
Gazyva is used to treat chronic lymphocytic leukemia (CLL) or follicular lymphoma (FL) in adults ...
Treanda
Treanda (bendamustine) is used to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Vitamin B6
Vitamin B6 is used for anemia, dietary supplementation, drug induced vitamin/mineral deficiency ...
Are you taking this medicine?
Your review helps others make informed decisions.Learn more about Follicular Lymphoma
Care guides
More about lenalidomide
- Check interactions
- Compare alternatives
- Reviews (40)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
"Revlimid has put my follicular lymphoma in remission. For 21 years, other drugs have had a similar effect. However, Revlimid caused a very strong reaction on my skin, which, along with another side effect, led my oncologist to suspend the treatment before the expected end. That other side effect is glaucoma in both eyes. I have practically lost vision in my left eye. I have no definitive proof of this, but I noticed a rapid decline in my vision after starting the drug, and it improved when the drug was stopped. Another oncologist shared similar experiences with some patients. In summary, I am in remission two years after stopping the treatment, but with only one functioning eye."